IL-1α stimulation of osteoclast survival through the PI-3 kinase/Akt and ERK pathways

被引:66
作者
Lee, SH
Lee, SE
Kim, CW
Lee, SH
Kim, SW
Kwack, K
Walsh, K
机构
[1] Chosun Univ, Sch Dent, Dong Gu, Gwangju 501759, South Korea
[2] Chosun Univ, Natl Res Lab Bone Metab, Gwangju 501759, South Korea
[3] Chosun Univ, Res Ctr Proteineous Mat, Gwangju 501759, South Korea
[4] Natl Inst Hlth, Seoul, South Korea
[5] Tufts Univ, Sch Med, Div Cardiovasc Res, Boston, MA 02111 USA
关键词
Akt; ERK; interleukin-1; osteoclast; survival;
D O I
10.1093/oxfordjournals.jbchem.a003071
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Osteoclasts, cells that resorb bone, die once fully differentiated. Several factors including interleukin-1 (IL-1) have been shown to regulate the survival of mature osteoclasts. However, information on the mechanism underlying the regulation of osteoclast survival has been limited. In this study, we investigated the mechanism for the IL-1-stimulated survival of osteoclasts. Treatment of purified osteoclasts with IL-1alpha led to activation of the serine-threonine kinases Akt and ERK. Blocking the activation of Akt with LY294002, a specific inhibitor of the Akt up-stream molecule PI 3-kinase, or with an adenoviral vector for a dominant-negative form of Akt prevented the stimulation of osteoclast survival by IL-1alpha. PD98059, a specific inhibitor of the ERK-activating kinase MEK1, also abolished the effects of IL-1alpha on ERK activation and osteoclast survival. IL-1alpha reduced the apoptosis of osteoclasts by reducing caspase 3 activity. The IL-1alpha-mediated suppression of apoptosis was abolished by the PI 3-kinase/Akt or ERK pathway inhibitor. These findings implicate the PI 3-kinase/Akt and ERK signaling pathways in the promotion of osteoclast survival by IL-1alpha.
引用
收藏
页码:161 / 166
页数:6
相关论文
共 29 条
[1]   Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms [J].
Bonni, A ;
Brunet, A ;
West, AE ;
Datta, SR ;
Takasu, MA ;
Greenberg, ME .
SCIENCE, 1999, 286 (5443) :1358-1362
[2]   EFFECTS OF INTERLEUKIN-1 ON BONE TURNOVER IN NORMAL MICE [J].
BOYCE, BF ;
AUFDEMORTE, TB ;
GARRETT, IR ;
YATES, AJP ;
MUNDY, GR .
ENDOCRINOLOGY, 1989, 125 (03) :1142-1150
[3]   TARF6 is a signal transducer for interleukin-1 [J].
Cao, ZD ;
Xiong, J ;
Takeuchi, M ;
Kurama, T ;
Goeddel, DV .
NATURE, 1996, 383 (6599) :443-446
[4]   IRAK: A kinase associated with the interleukin-1 receptor [J].
Cao, ZD ;
Henzel, WJ ;
Gao, XO .
SCIENCE, 1996, 271 (5252) :1128-1131
[5]   Norman Barrett: So close, yet 50 years away from the truth [J].
Chandrasoma, P .
JOURNAL OF GASTROINTESTINAL SURGERY, 1999, 3 (01) :7-14
[6]   Cellular survival: a play in three Akts [J].
Datta, SR ;
Brunet, A ;
Greenberg, ME .
GENES & DEVELOPMENT, 1999, 13 (22) :2905-2927
[7]   Requirement for NF-κB in osteoclast and B-cell development [J].
Franzoso, G ;
Carlson, L ;
Xing, LP ;
Poljak, L ;
Shores, EW ;
Brown, KD ;
Leonardi, A ;
Tran, T ;
Boyce, BF ;
Siebenlist, U .
GENES & DEVELOPMENT, 1997, 11 (24) :3482-3496
[8]  
Fujio Y, 1999, MOL CELL BIOL, V19, P5073
[9]  
GUAN Z, 1996, AM J PHYSIOL, V270, P634
[10]   Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells [J].
Hofbauer, LC ;
Lacey, DL ;
Dunstan, CR ;
Spelsberg, TC ;
Riggs, BL ;
Khosla, S .
BONE, 1999, 25 (03) :255-259